A recent CDC MMWR report described the BA.3.2 SARS-CoV-2 variant, nicknamed "cicada," as a new lineage of COVD-19 virus. The WHO considers it a variant under monitoring.

A variant of COVID-19 called BA.3.2, which has circulated under the radar since late 2024, is now spreading quickly across the United States. As a pulmonary and critical care doctor, I see many patients who are at high risk for severe COVID-19 due to chronic lung disease,

German researchers writing in The Lancet found that BA.3.2 beat six other covid variants at evading antibodies produced by the reigning (2025–2026) LP.8.1-adapted mRNA covid-19 vaccine—which is, perhaps, as good an explanation as any for the new variant’s rapid European tour.

A new Covid-19 subvariant, BA.3.2, nicknamed Cicada, is being tracked in the US and other countries. Experts say it carries multiple mutations, may evade immunity, but currently shows no clear rise in severe illness.

A mutated strain of the COVID-19 virus, first detected in the U.S. in a traveler to SFO, is increasingly appearing across the country.  A March 19 report from the U.S. Centers of Disease Control and Prevention detailed the rise of the COVID-19 BA.

A highly mutated variant of the SARS-CoV-2 virus, which causes COVID-19, has been detected in a number of countries. The variant, called BA.3.2, was first detected in South Africa way back in November 2024,

A new paper in Genome Biology and Evolution, indicates that while the COVID-19 virus has developed rapidly since 2019, it has done so within limited genetic channels. These genetic limits have remained unchanged.